Trombopanel Genetic is especially beneficial for individuals with a family history of thrombophilia, where the risk of developing thrombosis can be as high as 50%.
One of the main factors that cause or increase the risk of miscarriage is blood clotting.
According to official WHO data, 20% of pregnancies worldwide end in miscarriage.
In Latin America, it is estimated that one third of all women have a miscarriage at some time in their reproductive years.
Fortalece tus conocimientos sobre ti para mejorar tu salud.
It is important to mention that not all individuals with these mutations will develop health problems; however, in the presence of other risk factors, such as family history or unhealthy lifestyles, the risk may be increased. Therefore, the detection of these mutations can be useful to establish preventive strategies, such as folate supplementation, to reduce homocysteine levels and the associated risk, as well as personalized preventive and therapeutic measures to reduce the risk of thrombosis and stroke in these patients.
¿En qué se basa el estudio?
This analysis detects mutations in specific genes such as AGT, F2, F5, F7, FGB, MTR, MTRR, MTHFR, and SERPINE1. For example, mutations in the F2 and F5 genes can significantly increase the risk of thrombotic events.
Además, se buscan variantes genéticas C677T y A1298C en el gen MTHFR asociadas con alteraciones en el metabolismo del folato y pueden llevar a niveles elevados de homocisteína en la sangre, conocida como hiperhomocisteinemia. La hiperhomocisteinemia es un factor de riesgo para enfermedades tromboembólicas y cardiovasculares. La mutación C677T, en particular, resulta en una variante termolábil de la enzima MTHFR con capacidad reducida para metabolizar la homocisteína, lo que puede aumentar el riesgo de trombosis venosa profunda y otras complicaciones cardiovasculares.
- AGT
- AGT
- F2
- F5
- F7
- FGB
- MTR
- MTRR
- MTHFR
- MTHFR
- SERPINE1
For whom is the genetic thrombopanel study recommended?
- Está dirigido a mujeres que haya sufrido algún miscarriage in the trajectory of his life.
- Genetic analysis provides 99% accuracy in the identification of genetic variants related to the coagulation and allows for better management of the risk associated with the use of contraceptives.
- The detection of these mutations can be useful for establishing preventive strategies, such as supplementation with folates, to reduce the levels of homocysteine and the associated risk, as well as personalized preventive and therapeutic measures to reduce the risk of thrombosis and stroke in these patients.
Genetic Thrombosis Panel
- Digital and in-app reporting
La muestra se obtiene fácilmente mediante saliva con hisopos bucales, es indolora y puedes tomarla tú mismo con el kit; los resultados están disponibles en aproximadamente 7 días hábiles. Este estudio forma parte de nuestra oferta de medicina genómica y puede complementarse con módulos como farmacogenética, nutrigenética y dermagenética para mejorar tu calidad de vida.